Showing 741 - 760 results of 1,851 for search '"Texas A', query time: 0.07s Refine Results
  1. 741
  2. 742
  3. 743
  4. 744
  5. 745
  6. 746
  7. 747
  8. 748
  9. 749
  10. 750
  11. 751

    Update on Surgical Techniques Best Practices to Optimize Outcomes Following Gel Stent Implantation by Vera V, Sheybani A, Panarelli JF, Grover DS, Lee J, Craven ER, Samuelson TW, Ahmed IIK

    Published 2025-01-01
    “…Vanessa Vera,1 Arsham Sheybani,2 Joseph F Panarelli,3 Davinder S Grover,4 James Lee,5 Earl Randy Craven,2 Thomas W Samuelson,6 Iqbal Ike K Ahmed7 1Allergan, an AbbVie company, Irvine, CA, USA; 2Washington University School of Medicine, St Louis, MO, USA; 3Department of Ophthalmology, New York University Langone Health, New York, NY, USA; 4Glaucoma Associates of Texas, Dallas, TX, USA; 5Colorado Eye Institute, Colorado Springs, CO, USA; 6Minnesota Eye Consultants, University of Minnesota, Minneapolis, MN, USA; 7John Moran Eye Center, University of Utah, Salt Lake City, UT, USACorrespondence: James Lee, Colorado Eye Institute, Colorado Springs, CO, 80924, USA, Email jlee@eyescolorado.comAbstract: The XEN® 45 Glaucoma Treatment System (gel stent; Allergan, an AbbVie company, Irvine, CA, USA) is a minimally invasive bleb-forming surgical device that was originally approved to lower intraocular pressure by diverting the aqueous humor from the anterior chamber to the subconjunctival space (like trabeculectomy) following ab-interno placement. …”
    Get full text
    Article
  12. 752
  13. 753
  14. 754
  15. 755

    Evaluación morfológica del cultivar de buffelgrass "Lucero INTA-PEMAN" en condiciones de sequía by S. GRIFFA, A. RIBOTTA, C. LUNA, G. BOLLATI, E. LÓPEZ COLOMBA, E. TOMMASINO, E. CARLONI, M. QUIROGA, K. GRUNBERG

    Published 2011-01-01
    “…Fue superior en caracteres de producción de biomasa al Texas-4464 y en la mayoría de los mismos a los cultivares Biloela y Molopo. …”
    Get full text
    Article
  16. 756
  17. 757
  18. 758
  19. 759
  20. 760